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Purpose: To screen α-crystallin (CRYAB), γ-crystallin (CRYGC and CRYGD), and Connexin 50 (Cx-50 or GJA8) genes
in congenital cataract patients and controls.
Methods: Thirty clinically diagnosed congenital cataract cases below 3 years of age from northern India, presenting at
Dr. R. P. Centre for Ophthalmic Sciences (AIIMS, New Delhi, India) were enrolled in this study. Genomic DNA was
extracted from peripheral blood, all coding and exon/intron regions were amplified using PCR and direct sequencing was
performed to detect any nucleotide variation. ProtScale and Discovery Studio programs were used for insilico and
structural analysis of non-synonymous mutations.
Results: DNA sequencing analysis of CRYAB, CRYGC, CRYGD, and GJA8 showed a total of six variations of which two
were novel (CRYGC:p.R48H and GJA8:p.L281C) and four have been previously reported (CRYAB: rs11603779T>G,
GJA8: p.L268L, CRYGD: p.R95R, and c.T564C). Both the novel changes, in CRYGC and GJA8 were found in 16.6% of
the patients. Previously reported nucleotide alterations (CRYGD:p.R95R and c.T564C) were found in 90% of the patients.
Insilico and structural analysis data suggested that two novel non-synonymous mutations altered the stability and solvent
accessibility of γC-crystallin and Cx-50 proteins which may lead to lens opacification.
Conclusions: We observed two novel nonsynonymous variations and four reported variations in CRYAB, CRYGC,
CRYGD, and GJA8. The p.R48H variation in γC-crystallin may disrupt the normal structure of lens and can cause cataract.
Cx50 is responsible for joining the lens cells into a functional syncytium and a mutation (p.L281C) in GJA8 may lead to
lens opacification resulting in cataract formation. This study further expands the mutation spectrum of congenital cataract
and help understanding how mutant proteins lead to opacification of lens.
Cataract is an opacification of the lens resulting from
alterations in lens cellular architecture or in lens proteins, or
both.  Congenital  cataract  is  a  clinically  and  genetically
heterogeneous  lens  disease  responsible  for  a  significant
proportion of visual impairment and blindness in childhood
[1,2]. The prevalence of congenital cataract is estimated to
vary from 0.6 to 6 per 10,000 live births with an incidence of
2.2–2.49  per  10,000  live  births  [3].  It  is  estimated  that
globally, 20 million children under the age of 16 years suffer
from cataract, and among these, 200,000 (15%) are severely
visually  impaired  or  blind  [4,5].  Pediatric  cataracts  are
responsible  for  7.4%  to  15.3%  of  childhood  blindness  in
developing  countries  like  india  [6-8].  The  prevalence  of
blindness in children ranges from approximately 0.3/1000
children  in  affluent  regions  to  1.5/1000  in  the  poorest
communities. The population of India in 2001 was estimated
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to be 1.03 billion, approximately 420 million of whom are
children under 16 years of age (40.9%). Overall, there are
probably  280,000–320,000  blind  children  in  India  [9].
Cataract is responsible for ~12% of childhood blindness in
India [6,10]. The occurrence of congenital cataract varies in
different parts of India as it is 5.25% in northen India [7], 8.5%
in northeast states [6], 7.25% in western India [11] and 11.4%
in south India [12].
Currently there are ~60 loci implicated in non-syndromic
congenital  cataract,  among  these,  over  22  have  been
associated with mutations in specific genes [13-15] including
10  crystallin  genes:  αA-crystallin  (CRYAA),  αB-crystallin
(CRYAB),  βA1-crystallin  (CRYBA1),  βA4-crystallin
(CRYBA4),  βB1-crystallin  (CRYBB1),  βB2-crystallin
(CRYBB2),  βB3-crystallin  (CRYBB3),  γC-crystallin
(CRYGC),  γD-crystallin  (CRYGD),  γS-crystallin  (CRYGS)
[16-21],  two  cytoskeletal  protein  genes:  beaded  filament
structural  protein  1,  filensin  (BFSP1),  beaded  filament
structural protein 2, phakinin (BFSP2) [22], four membrane
protein  genes:  gap  junction  protein  (alpha  3,  GJA3),  gap
junction protein (alpha 8, GJA8), major intrinsic protein of
lens fiber (MIP), and lens intrinsic membrane protein 2 gene
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693(LIM2) [23-25], three growth and transcription factor genes:
heat  shock  transcription  factor  4  (HSF4),  paired-like
homeodomain 3 (PITX3), Maf-like protein (MAF) [26,27],
and  chromatin  modifying  protein-4B  (CHMP4B),  Ephrin
receptor  EphA2  (EPHA2),  and  Nance-Horan  syndrome
(NHS) [27].
As crystallin genes account for nearly 90% of the water
soluble proteins in lens and the encoded proteins account for
around 30% of lens mass, these proteins play an essential roles
in  maintaining  the  lens  transparency  [28]  and  are  good
candidate genes for screening in congenital cataract patients.
Crystallin  mutations  accounts  for  about  50%  of  the  non
syndromic  cataract  [14].  Since  the  lens  is  an  avascular
structure, the crystallins are retained in soluble form through
the maintenance of ionic balance by the actions of gap junction
proteins which allow the metabolically active epithelium to
regulate  the  precise  inter-cellular  communication  and
transport between the lens periphery and its interior. Gap
junction proteins (alpha 3 and alpha 8) are expressed in the
lens vesicle and mutations in these genes have been reported
to lead to cataract [29-31].
Congenital cataract is the most important treatable cause
of pediatric blindness in developing countries like India. In
this pilot study, we screened 30 cases of congenital cataract
for sequence variations in CRYAB, CRYGC, CRYGD, and
GJA8.  Upon  sequence  analysis  we  detected  six  sequence
variations. Out of six, two novel mutations were found in
CRYGC  (R48H)  and  GJA8  (L281C).  The  probable
pathogenicity of the mutations found in this study as disease
causing is discussed in light of earlier studies.
METHODS
Clinical examination and selection of cases: After receiving
ethical  approval  from  the  institutional  review  board
(IRB#00006862;  All  India  Institute  of  Medical  Sciences,
Delhi, India), 30 clinically diagnosed consecutive congenital
cataract  cases  below  3  years  of  age  from  northern  India,
presenting at the Dr. R. P. Centre for Ophthalmic Sciences
(AIIMS, New Delhi, India) were enrolled in this study. These
congenital cataract cases had no other ocular or systemic
abnormalities.  Detailed  history  was  taken  from  parents
regarding high fever, TORCHES ([Toxoplasma gondii; T.
gondii], rubella virus [RV], cytomegalovirus [CMV], herpes
simplex  virus  [HSV],  syphilis  [caused  by  Treponema
pallidum]) infection, tuberculosis, exposure to radiation, and
drug intake during gestation period. Metabolic tests like serum
biochemistry  for  levels  of  blood  glucose,  calcium  and
phosphorous evaluations, RBC transferase and galactokinase
levels and urine test for reducing sugars (galactosemia) and
for amino acids (Lowe syndrome) were also done. Cases with
known cause of congenital cataract were excluded from the
study. Affected status was determined by a history of cataract
extraction  or  ophthalmologic  examination.  A  total  of  30
ethnically and age-matched normal individuals without any
history  of  ocular  or  systemic  disorders  were  enrolled  as
controls. They had no metabolic, genetic, or ocular disorder
on examination by a ophthalmologist and an extensive history
was  taken  regarding  family,  occupation  of  parents,  any
medical  problem,  and  drug  intake  by  parents.  Informed
consent in accordance with the Declaration of Helsinki was
obtained from all participants or their parents and controls.
DNA isolation, PCR amplification and sequence analysis:
Genomic DNA was extracted from whole blood samples of
all cases and controls, using organic method as described by
Sambrook et al. [32] with some modifications. Briefly, 5 ml
blood  was  incubated  in  15  ml  of  Red  Cell  Lysis  Buffer
(RCLB) at 4 °C and then centrifuged at 6,861× g for 15 min
at  4  °C.  Supernatant  was  discarded  and  pellet  was  given
repeated washes with RCLB till the pellet became white. The
white pellet was re-suspended in 5 ml of DNA extraction
buffer, 40 µl of proteinase-K (40 µg/ml) and 300 µl of sodium
dodecyl sulphate (SDS). The cocktail was incubated at 55 °C
for 2-3 h. The digested proteins were precipitated by adding
equal  volumes  of  saturated  phenol  and
chloroform:isoamylalcohol (24:1). The mixture was gently
mixed on rotor-mixer for 15-20 min and then centrifuge at
6,861× g for 15 min at 4 °C. In upper viscous layer equal
amount  of  chloroform:isoamylalcohol  (24:1)  solution  was
added and again mixed for 15 min in rotor-mixer. The aqueous
layer containing the genomic DNA was carefully collected.
TABLE 1. OLIGONUCLEOTIDES USED AS PRIMERS FOR PCR AMPLIFICATION OF CRYAB,  CRYGC, CRYGD, AND GJA8 AND THEIR ANNEALING TEMPERATURES.
Gene (exon) Forward primer (5′→3′) Reverse primer (5′→3′) Temperature (°C)
CRYAB (1) CCTGACATCACCATTCCAGA GGCAGGGTAGGAAAGGAAA 51
CRYAB (2) TGCAGAATAAGACAGCACCTG CCAGCCTCCAAAGCTGATAG 54
CRYAB (3) TGTTGTCATGGCATTTGGTC TCATTCACTGGTGGGGAAA 57
CRYGC (1,2) CAGCCATCCTGCTATATAG GGCATGATGGAAATCTAG 50
CRYGC (3) GTTGGACAAATTCTGGAA GCACAATGAAAGAATGAC 45
CRYGD (1) AGAACACGAAAATGCCCTTG GTCTCACAGGCCTGCTCCT 55
CRYGD (2) GAGCTTCCTCCATCGC CCTGGGTCCTGACTTGA 48
CRYGD (3) GCTGGACTGCCTAACAATGC CACATCTTGGTTGCCATTTG 55
GJA8 (1) TATGGGCGACTGGAGTTTCCT CTCCATGCGGACGTAGTGCAC 65
GJA8 (2) CTCTGGGTGCTGCAGATCATC CACAGAGGCCACAGACAACAT 55
GJA8 (3) CACTACTTCCTGTACGGGTTC CTCTTGGTAGCCCCGGGACAA 60
GJA8 (4) GTCTCCTCCATCCAGAAAGCC TCATACGGTTAGATCGTCTGA 58
Molecular Vision 2011; 17:693-707 <http://www.molvis.org/molvis/v17/a79> © 2011 Molecular Vision
694Then  DNA  was  precipitated  with  chilled  ethanol  and
centrifugation at 1,461.6× g for 15 min. DNA pellet was
washed with 70% ethanol and dissolved in TE buffer. The
exon-intron regions of CRYAB, CRYGC, CRYGD, and GJA8
were amplified in congenital cataract patients and controls.
PCR  amplifications  for  all  primer  sets  (Table  1)  were
performed in a 40 μl volume containing 1.0 μl of 20 mM stock
solution for each primer (Eurofins Genomics India pvt Ltd,
Bangalore, India), 100 ng of genomic DNA, 1 unit of Taq
polymerase (Banglore Genei, Bengaluru, Karnataka, India),
0.1 mM of each deoxynucleotide triphosphate (dNTP), and
4 μl of 10× PCR buffer (with 15 mM MgCl2). Amplified PCR
products  were  purified  using  a  gel/PCR  DNA  fragments
extraction kit (Geneaid Biotech Ltd., Sijhih City, Taiwan).
Purified PCR products were sent for sequencing to Molecular
Cloning  Laboratories  (South  San  Francisco,  CA).  All
fragments  were  sequenced  in  both  forward  and  reverse
directions  for  confirmation  of  any  nucleotide  variation  in
congenital cataract patients and controls and compared to the
Human Genome Reference Sequence (NC_000002.11 and
NC_000001.10)  provided  by  the  National  Center  for
Biotechnology  Information  (NCBI),  using  ClustalW2
(multiple sequence alignment program for DNA; European
Bioinformatics Institute, Wellcome Trust Genome Campus,
Hinxton, Cambridge, UK).
Computational assessment of missense mutations: We used
an evolutionary model to predict the functional consequence
of genetic variation in the ATP-binding cassette, sub-family
A  (ABC1),  member  1  gene  and  tested  these  predictions
through in vitro assessments of protein function [33]. We
predicted the functional consequence of each variant using
PANTHER. The probability that a given coding variant will
cause  a  deleterious  functional  change  is  estimated  by  the
substitution position-specific evolutionary conservation (sub-
PSEC)  score.  SIFT  (Sorting  Intolerant  From  Tolerant)
analysis tool was also used to predict the functional impact of
missense changes identified in this study. SIFT is a sequence
homology based tool that sorts intolerant from tolerant amino
acid  substitutions  and  predicts  whether  an  amino  acid
substitution in a protein will have a phenotypic effect [34].
SIFT  is  based  on  the  premise  that  protein  evolution  is
correlated with protein function. Positions with normalized
probabilities less than 0.05 are predicted to be deleterious and,
those greater than or equal to 0.05 are predicted to be tolerated
in case of SIFT. We have also used an improved splice site
predictor tool [35] to predict whether a nucleotide change is
likely to create a splice site.
Protein  modeling:  The  normal  and  mutant  proteins  were
analyzed for their structure. Prediction of structure differences
between wild and mutant were performed using Discovery
Studio (DS) 2.0 (Accelrys Inc., San Diego, CA) [36]. The first
step  in  homology  modeling  method  was  to  find  suitable
homologus structure (template). Comparative modeling for
GJA8 was not possible as the homology model has only 21%
sequence identity whereas homology model for human γC-
crystallin has 84% sequence identity, thus the comparative
Figure 1. Different types of cataract. A:
Nuclear cataract: The eye picture shows
opacity  of  both  lenses  in  one  of  the
patient.  B:  Zonular/lamellar  cataract:
The zonular/lamellar cataract in one of
the patient. C: Polar Cataract: Anterior
polar cataract phenotype shown by one
of the patient. D: Total Cataract: total
cataract phenotype found in one patient.
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)modeling  for  human  γC-crystallin  was  possible  using
homology model.
Comparative  modeling  of  human  γC-crystallin:  The  best
available template for the modeling of 3-D structure of the
human γC-crystallin was a high resolution (1.9 Å) crystal
structure of mouse γC-crystallin (PDB ID=2V2U) [37]. The
sequence identity and similarity between human and mouse
γC-crystallin was found to be 84% and 91%, respectively.
This template was used to build the homology model of human
γC-crystallin using MODELER 9.2 program [38,39] available
in Discovery Studio (DS) 2.0 (Accelrys Inc., San Diego, CA),
a software package for molecular modeling and simulation.
The model with the lowest energy among all the generated
models was taken and its stereochemistry checked using the
Ramachandran  plot.  The  native  model  was  solvated  and
further minimized using the available molecular dynamics
(MD)  simulation  protocols  to  ensure  the  stability  of  the
generated model. The 3-D model structure of human γC-
TABLE 3. NUCLEOTIDE VARIATIONS FOUND IN CONGENITAL CATARACT PATIENTS.
Sample
number
Nucleotide change Locus Codon change Amino acid
change
Type of
mutation
PANTHER/SIFT score Frequency
1 rs11603779T>G^ CRYAB intronic N/A N/A N/A 13.33%
2 c.G181A* CRYGC CGT>CAT R48H NS −2.72/1.00 13.33%
3 c.T564C^ CRYGD 3′UTR N/A N/A N/A 76.66%
4 c.A313G^ CRYGD AGA>AGG R95R SYN N/A 93.33%
5 c.C857T^ GJA8 CTC>CTT L268L SYN N/A 3.3%
6 c.T905C* GJA8 TTG>TCG L281C NS −3.97/0.00 3.3%
          (Abbrevations: *Novel variations, ^Reported- ensembl, SYN-synonymous, NS-Non-synonymous, N/A-Not applicable).
Figure 2. CRYGC DNA sequence in an
affected and an unaffected individual.
A: DNA sequence electropherogram of
an unaffected individual showing wild
type  G  at  position  181.  B:  DNA
sequence electropherogram showing the
heterozygous 181G>A substitution that
replaces Arginine by Histidine at codon
48  in  the  affected  individual.  The
position of mutated (G>A) and wild type
nucleotide  G  in  an  affected  and  an
unaffected  individual  is  indicated  in
box.
Figure 3. Multiple sequence alignment of the fourth Greek key motif of CRYGC is shown from Homo sapiens (codons 1–62), Macaca mulatta,
Canis lupus, Bos Taurus, Rattus norvegicus, Mus musculus, and Pan troglodytes. The Arg48 residue is highly conserved.
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698crystallin mutant (Arg48His) was developed taking the model
structure of wild type human γC-crystallin by using the “Build
Mutant” protocol and altering the corresponding residue from
Arg to His. The built model of mutant was optimized similar
to the wild-type human γC-crystallin. The explicit solvent MD
simulation was also performed similar to the wild type human
γC-crystallin.
Statistical  analysis:  The  correlation  coefficient  between
mutations in crystallin and gap junction protein genes and
parameters  like  degree  of  opacification,  morphology  of
congenital  cataract,  and  visual  acuity  were  calculated  by
spearman's  test.  p-value  less  than  0.05  is  considered  as
significant.  Statistical  analyses  were  performed  using
graphpad software (GraphPad Software, Inc., La Jolla, CA).
TABLE 4. SUMMARY OF THE MUTATIONS IDENTIFIED IN CRYGD, CRYGC, AND GJA8 WITH DIFFERENT CONGENITAL CATARACT PHENOTYPES BELONGING
TO DIFFERENT ETHNIC GROUPS.
Gene Nucleotide Amino acid Phenotype Ethnicity Reference
CRYGD c.43C>T p.Arg15Cys Punctate cataract, juvenile
progressive, Coralliform/
nuclear
Caucasian,
Chinese
[70]
CRYGD c.43C>A p.Arg15Ser Coralliform Chinese [71]
CRYGD c.70C>A p.Pro24Thr Lamellar, Cerulean Coral-
shaped- coralliform, Flaky-
silica-like nuclear cataract,
Fasciculiform
Indian, Moroccan,
Caucasian,
Australian,
Chinese, Saudi
Arabian
[46,72]
CRYGD c.109C>A p.Arg37Ser with protein crystallization,
Nuclear golden crystal
Czech boy,
Chinese
[73]
CRYGD c.168C>G p.Tyr56Stop Nuclear Brazilian [74]
CRYGD c.176G>A p.Arg59His Aculeiform Macedonian [44]
CRYGD c.181G>T p.Gly61Cys Coralliform Chinese [75]
CRYGD c.320A>C p.Glu107Ala Nuclear Hispanic [76]
CRYGD c.403C>A p.Tyr134Stop No data Danish [69]
CRYGD c.418C>T p.Arg140Stop Nuclear Indian [41]
CRYGD c.470G>A p.Trp157Stop Nuclear Indian [46]
CRYGD c.494delG p.Gly165fs Nuclear Chinese [72]
CRYGD c.229C>A p.Arg77Ser Anterior polar, Coronary Indian [77]
CRYGC c.13A>C p.Thr5Pro Coppock-like ---- [44]
CRYGC c.123insGCGGC p.Gly41delinsGlyfsX62 Zonular pulverulent ---- [45]
CRYGC c.502C>T p.Arg168Trp Lamellar/nuclear ---- [46]
CRYGC c.327C>A p.Cys109X Nuclear Chinese [47]
CRYGC c. 181G>A p.Arg48His Zonular and nuclear cataract North Indian Present study
GJA8 c.68G>C p.Arg23Thr Progressive dense nuclear Iranian [54]
GJA8 c.92T>C p.Ile31Thr Nuclear cataract Chinese [55]
GJA8 c.131T>A p.Val44Glu Cataract and microcornea Indian [68]
GJA8 c.134G>C p.Trp45Ser Jellyfish-like cataract and
microcornea
Indian [56]
GJA8 c.139G>A p.Asp47Asn Nuclear pulverulent cataract English [57]
GJA8 c.139G>T p.Asp47Tyr Nuclear cataract Chinese [58]
GJA8 c.142G>A p.Glu48Lys Zonular nuclear pulverulent Pakistani [59]
GJA8 c.191T>G p.Val64Gly Nuclear cataract Chinese [60]
GJA8 c.235G>C p.Val79Leu Full moon like with Y-sutural
opacities
Indian [61]
GJA8 c.262C>T p.Pro88Ser Zonular pulverulent English [62]
GJA8 c.262C>A p.Pro88Gln “Balloon-like”cataract with
Y-sutural opacities
English, Indian [63]
GJA8 c.565C>T p.Pro189Leu Nuclear cataract and
microcornea
Danish [69]
GJA8 c.593G>A p.Arg198Gln Posterior subcapsular
cataract and microcornea
Indian [68]
GJA8 c.670insA Fs Total cataract and nystagmus Indian [64]
GJA8 c.741T>G p.Ile247Met Zonular pulverulent cataract Russian [65]
GJA8 ins776G Fs Triangular nuclear cataract German [66]
GJA8 c.827C>T p.Ser276Phe Pulverulent nuclear cataract Chinese [67]
GJA8 c. 905T>C p.Leu281Cys Zonular Cataract North Indian Present study
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699RESULTS
Clinical findings: A total of 30 congenital cataract patients
below 3 years of age were enrolled in this study. The mean
age of the patients was 1.75±0.19 years (one month to 3 years).
The age of onset was recorded as the age at which the disease
was first noticed by the parents or first documented by a
clinician.  All  cases  were  sporadic  and  were  enrolled
consecutively  as  they  presented  to  Dr.  R.P.  Centre  for
Ophthalmic Sciences. In this study 20 cases were males and
10  were  females.  None  of  the  cases  were  product  of
consanguineous  marriage  and  all  cases  had  bilateral
congenital  cataract.  The  cataract  phenotype  varied  among
patients as 66.66% (20/30) of patients had nuclear cataract
(Figure 1A), 23.33% (7/30) had zonular/lamellar type cataract
(Figure 1B), 6.66% (2/30) had anterior polar cataract (Figure
1C), and 3.3% (1/30) had total cataract (Figure 1D; Table 2).
In this study 93% cases were detected with one or the other
nucleotide  alterations  in  CRYAB,  CRYGC,  CRYGD,  and
GJA8.  Six  nucleotide  variations  were  detected  in  patients
(Table 3). 66% nucleotide changes were found in crystallin
genes (CRYAB, CYRGC, and CRYGD) and 44% were detected
in connexin (GJA8). Of the six mutations identified, two were
novel and four have been reported.
Summary of mutations in α-crystallin genes: The α-crystallin
gene family consists of two similar genes coding for αA-
crystallin (CRYAA located on chromosome 21q22.3) and αB-
crystallin (CRYAB on chromosome 11q22.1) sharing 57%
sequence identity. CRYAB contains 3 exons which encodes a
175  amino  acid  protein.  Direct  sequencing  of  the  coding
regions and of the flanking intronic sequences of CRYAB
revealed  one  nucleotide  change  (rs11603779T>G)  in  the
intronic region between exon 2 and 3 of CRYAB. The variation
was found in 13.33% (4/30) case of congenital cataract. No
nucleotide changes were found in controls. Improved splice
site prediction for rs11603779T>G showed that this location
is not present at splice site and may not create a splicing error
in CRYAB.
Figure 4. GJA8 DNA sequence in an
affected and an unaffected individual.
A: DNA sequence electropherogram of
an unaffected individual showing wild
type  T  at  position  905.  B:  DNA
sequence electropherogram showing the
heterozygous 905T>C substitution that
replaces Leucine by Cysteine at codon
281  in  the  affected  individual.  The
position of mutated (T>C) and wild type
nucleotide  G  in  an  affected  and  an
unaffected individual is indicated in the
box.
Figure 5. Multiple sequence alignment of the fourth Greek key motif of GJA8 is shown from Homo sapiens (codons 243–290), Pan troglodytes,
Canis lupus, Bos Taurus, Mus musculus, Gallus gallus and Danio rerio. The Lys281 residue is highly conserved.
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700Summary of mutations in γ-crystallin genes: The γ-crystallin
gene family is mainly located in a cluster of six highly related
genes  (CRYGA-CRYGF)  on  human  chromosome  2q33–35
and the seventh CRYG gene (CRYGS) on human chromosome
3. Mutations in CRYGC and CRYGD have been associated
with  congenital  and  hereditary  cataract  (Table  4).  Direct
sequencing of the coding region and of the flanking intronic
sequences of CRYGC and CRYGD revealed three sequence
variations. One heterozygous nucleotide change (c.G181A)
was detected in exon 2 of CRYGC, resulting in the substitution
of Arg to His at codon 48 (p.R48H; Figure 2) and was found
in 13.33% (4/30) cases of congenital cataract. The multiple
sequence alignments generated using FASTA3 (version 3 at
the EBI) software showed that the Arg at position 48 of human
CRYGC  is  highly  conserved  in  Macaca  mulatta,  Canis
lupus, Bos taurus, Rattus norvegicus, Mus musculus, and Pan
troglodytes (Figure 3). Nucleotide change p.R48H was found
to be non-pathogenic on insilico analysis (PANTHER and
SIFT; Table 3). However as this change was in a highly
conserved domain it may adversely affect protein function.
None  of  the  nucleotide  changes  were  detected  in  control
group. Two nucleotide changes in CRYGD; c.A313G in exon
3, resulting in synonymous change (p.R95R; rs2305430) and
c.T564C (rs2305429) in the 3′UTR region, were also observed
in 28 and 23 patients, respectively.
Summary  of  mutations  in  the  GJA8  (Connexin-50)  gene:
Direct sequencing of the amplified fragments of GJA8 in
congenital  cataract  patients  identified  two  single  base
alterations (p.L268L and p.L281C). The change p.L268L was
found in 3.33% (1/30) case of congenital cataract with anterior
polar cataract whereas p.L281C (heterozygous) also found in
3.33% (1/30) cases. This case had lamellar/zonular form of
cataract  with  nystagmoid  movement.  Both  the  nucleotide
alterations (c.C857T and c.T905C) were in the second exon
of GJA8. The nucleotide alteration c.T905C resulted in a novel
amino acid substitution of leucine to cysteine at codon 281
(p.L281C;  Figure  4)  whereas  the  c.C857T  nucleotide
alteration leads to a synonymous amino acid substitution.
Figure 6. Sequence alignment of wild type human γC-crystallin and mouse γC-crystallin (PDB ID: 2V2U).
Figure  7.  Change  in  conformation  of
loop3  in  wild  type  (in  magenta)  and
mutant  (in  orange)  of  human  γC-
crystallin.
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701GJA8 family protein sequences were obtained from NCBI
website and multiple-sequence alignments of GJA8 family
proteins from various species were obtained (Figure 5) using
FASTA  (version  3  at  the  EBI).  This  changed  a
phylogenetically conserved leucine to cysteine at codon 281
(p.L281C). Computational analysis (PANTHER and SIFT) of
p.L281C predicted this nucleotide change as a pathogenic
variant (Table 3). The remainder of the GJA8 coding sequence
showed no change. In addition, these nucleotide changes were
not detected in 30 normal unrelated individuals from the same
ethnic background.
Comparative  modeling  study  of  γC-crystallin:  Since  the
sequence identity between target (human γC-crystallin) and
template  (mouse  γC-crystallin)  was  84%  (Figure  6),  the
structural reliability of the generated 3-dimensional homology
model was high. The stability of the modeled wild-type and
mutant  (Arg48His)  human  γC-crystallin  was  checked  by
performing  molecular  dynamics  simulation.  These  results
indicated that the structures were stable. Both the wild type
and  mutant  had  very  similar  conformation  with  good
geometry. The structure of wild type as well as mutant human
γC-crystallin  consisted  of  three  small  helices  (each  helix
contains  four  residues),  four  anti-parallel  β-strands  and
connecting loops (Figure 7).
In-silico analysis: PANTHER and SIFT online tools were
used for potential functional prediction of mutant proteins.
After input the amino acid sequences of the wild-type CRYGC
and GJA8 protein and their mutants, the PANTHER scores
were −2.72 and −3.97, respectively, whereas the SIFT scores
were 1.00 and 0.00, respectively, which meant that the variant
(CRYGC:p.R48H) was predicted as “non-pathogenic” and
the variant (GJA8:p.L281C) was predicted as “pathogenic”
with  high  confidence.  In  comparison  with  the  wild-type
CRYGC and GJA8 protein, the hydrophobicity of the mutants
CRYGC and GJA8 were dramatically increased (Figure 8).
The secondary structure of mutant and wild type amino acid
Figure 8. Hydrophobicity analysis. A:
Comparision  of  hydrophobicity
between wild type and mutant CRYGC.
The  protscale  online  software  predict
the  effect  of  substitution  on  CRYGC
protein  hydrophobicity.
Hydrophobicity  of  mutant  protein
increases  around  mutation  point
(R48H).  B:  Comparision  of
hydrophobicity between wild type and
mutant  GJA8.  The  protscale  online
software  predict  the  effect  of
substitution  on  GJA8  protein
hydrophobicity.  Hydrophobicity  of
mutant  protein  increases  around
mutation point (L281C).
Figure 9. The predicted secondary structure of the mutant and wild type amino acid sequences. Target sequences are shown by red box which
indicate that random coil has been replaced by the exented loop.
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702sequences of GJA8 were analyzed by Antheprot 2000ver. 6.0
software  (IBCP,  Lyon,France)  which  showed  that  the
mutation p.L281C lead to the replacement of random coil with
extended loop (Figure 9). This replacement may be sufficient
to change the secondary structure of the protein resulting in
lens opacification.
Genotype-phenotypes correlation: The genotype-phenotype
correlation  with  the  different  morphological  types  of
congenital cataract, their severity, visual acuity and different
mutations have been tabulated (Table 5). The genotype and
phenotype  correlation  coefficient  (r  value)  between
parameters  like  Degree  of  opacification,  morphology  of
congenital cataract, visual acuity and mutations, showed no
significance and hence no association between mutations and
different parameters. Therefore no particular type of cataract
was  found  to  be  associated  with  any  particular  mutant
phenotype.
DISCUSSION
The transparency and high refractive index of the lens are
achieved by the precise architecture of the fiber cells and the
homeostasis  of  the  lens  proteins  in  terms  of  their
concentration,  stability,  and  supramolecular  organization
[40]. In this pilot study we identified six nucleotide variations
(Table  3).  Crystallin  specific  mutations  (16.6%)  were
identified which is similar to the mutations detected in south
Indian population [41]. We also detected 16.6% GJA8 specific
variations in congenital cataract cases. We identified two non-
synonymous  novel  mutations,  p.R48H(4/30)  and
p.L281C(1/30) in CRYGC and GJA8, respectively. Crystallins
(α-, β-, and γ-crystallin) encode the major proportion of water
soluble  structural  proteins  of  the  lens  fiber  cells  and  are
ubiquitous lens proteins. Functional changes and alteration of
crystallin molecular properties could cause the breakdown of
the lens microstructure and result in changes in the refractive
index and increased light scattering.
Description  of  mutations  in  CRYGC  and  associated
phenotypes: It is reported that self aggregation or quaternary
structural  alteration  of  γ-crystallin  is  responsible  for  the
phenotypic  association  with  lens  opacification  as  well  as
cataractogenesis [42,43]. To the best of our knowledge, four
mutations  in  CRYGC  have  been  reported  in  the  literature
(Table 4) [44-47]. The mutation p.R48H involves substitution
of highly basic and polar charged Arginine with a neutral and
less polar Histidine which may cause conformational changes.
Arginine  has  well  spread  electron  density  enabling  high
solubility. It is a hydrophilic amino acid with a positive charge
and lies within the extended strand on the surface of the
molecule,  interacting  with  water.  Arginine  is  replaced  by
histidine, a hydrophobic amino acid compared to arginine. It
has been reported that changing the solvation property of an
amino acid residue on the surface of the γ-crystallin protein
diminishes its solubility [48]. The distorted γC-crystallin may
change its folding properties as shown in a study where the
COOH-terminal  domain  folds  before  and  nucleates  the
folding of the NH2-terminal domain in human γD-crystallin
refolding  [49].  The  relatively  loose  or  partially  unfolded
structure  of  mutant  γC-crystallin  may  be  susceptible  to
aggregation  and  insolubilization,  which  leads  to  cataract
formation [50]. Another possible consequence of the R48H
mutation may be related to the disturbances of the interactions
between γC-crystallin and other crystallins [51].
The overall conformation, secondary structure elements
and geometry of the conformers of wild-type and mutant
human  γC-crystallin  were  mainly  similar.  The  most
significant variation was observed in the conformation of the
loop 3 region involving residues 47–54 which houses the
mutation (Arg48His; Figure 7). The mutant has substitution
of  the  longer  and  basic  Arginine  by  a  shorter  Histidine
possessing an imidazole ring. Thus this mutation alters the
characteristic of this residue in both nature and length which
is  reflected  in  the  difference  in  its  interactions  with
neighboring amino acid residues The Arg48 in the wild type
interacts with its adjacent acidic residue Glu47 which in turn
forms a hydrogen bond with Gln54 thus stabilizing the loop 3
(Figure 10A). Thus the interaction of Glu47 with both residues
Arg48 and Gln54 imparts an orientation to loop3. In the case
of the mutant the shorter Histidine is no longer able to interact
with Glu47 but instead interacts with Gln52 (Figure 10B).
This loss of the stabilizing interaction enables Glu47 to adopt
a different orientation and it in turn interacts with Arg77 while
maintaining its interaction with Gln54. This alteration in the
TABLE 5. CORRELATION COEFFICIENT AND P VALUE BETWEEN CRYSTALLINS AND GAP JUNCTION PROTEIN GENE MUTATIONS AND VISUAL
PARAMETERS (DEGREE OF OPACIFICATION AND VISUAL ACUITY).
Mutations Degree of opacification Visual acuity
CRYGC:p.R48H r=0.1903, p=0.3139 r=-0.0747, p=0.6945
CRYGD:p.R95R r=0.0808, p=0.6711 r=-0.0490, p=0.7969
CRYGD:T564C r=0.0955, p=0.6154 r=0.04662, p=0.8067
CRYGD:rs11603779T>G r=0.0951, p=0.6170 r=0.0753, p=0.6922
GJA8:p.L268L r=-0.2252, p=0.2315 r=-0.1110, p=0.5594
GJA8:p.L281C r=-0.2252, p=0.2315 r=-0.2336, p=0.2394
Visual acuity r=0.1915, p=0.3100 –
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703orientation of Glu47 and subsequently its interacting residues
in  the  mutant,  results  in  the  modification  of  the  relative
orientation of the loop 3 comprising residues 47 to 54.
γ-Crystallins are long lived proteins of the lens and are
generally characterized by both high stability and solubility.
A key feature of γ-crystallins is that their surfaces are covered
in ion pairs. The Arg head groups are most accessible to
solvent water and therefore have a profound effect on the
surrounding  water,  particularly  important  in  lens.  Since
sequences of γ-crystallins are optimized for high solubility
and  minor  changes  to  the  surface  can  dramatically  alter
solution  interaction  properties.  So  the  changes  in  protein
conformations  can  decrease  in  solubility  and  stability  of
native protein which could result in aggregation of protein and
thus opacification of lens. The R48H mutation interferes with
the  formation  of  two  COOH-terminal  Greek  key  motifs.
Although the function of the Greek key motifs has not been
elaborated in detail, computer-based analysis suggests that it
may be responsible for particular protein–protein interactions
in the lens, and it is postulated to be critical in the maintenance
of lens transparency. The possible influence of the mutation
on  the  structure  as  well  as  the  function  of  γC-crystallin
requires further investigation.
Description  of  mutations  in  GJA8  and  associated
phenotypes:  GJA8  is  located  on  chromosome  1q21.1  and
encodes a 50 kDa protein (connexin 50; Cx50). Cx-50 is a
member of the connexin family of proteins that are important
in the formation of gap junction channels [52] in human lens
which are responsible for direct intercellular transfer of ions
and molecules between adjacent cells [53]. Since the eye lens
Figure 10. Hydrogen bond interactions.
A: Conformation of loop3 (in magenta)
in  wild  type  human  γC-crystallin.  B:
Conformation of loop3 (in orange) in
mutant (R48H) human γC-crystallin.
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704is an avascular structure, it relies heavily on an intercellular
communication  system  constructed  of  gap  junctions  for
preservation of tissue homeostasis and transparency [3,13].
Cx50 contains four transmembrane domains (M1, M2, M3,
and M4) linked by two extracellular loops (E1 and E2), as well
as an intracellular loop (CL), and intra-cytoplasmic NH2- and
COOH-termini  [54].  Mutant  connexins  are  unable  to
participate in gap junction formation [13] and inhibit channel
formation.  To  date,  22  mutations  have  been  detected  in
GJA8  in  association  with  congenital  cataract  (Table  4)
[54-69]. We identified a novel missense mutation, p.L281C,
in GJA8 in cases with congenital cataract (zonular/lamellar
cataract with nystagmus). Different mutations (Table 4) in the
connexin  gene  are  often  associated  pulverulent  nuclear
opacities [55,56,58,59,61,65,68,69]. However some studies
[60,63,67]  have  detected  mutations  in  GJA8  which  were
associated with zonular/lamellar cataract phenotype as we
found in this study. Insilico analysis of p.L281C mutation
showed  that  the  hydrophobicity  of  the  mutant  protein
increased while the hydrophobic moment decreased (Figure
8). The predicted new characteristics of the mutant protein,
which include altered interactions with other proteins, altered
regulation activities of GJA8, and altered assemblies, may be
the cause of the disease.
Our findings further expand the mutation spectrum of
GJA8 and CRYGC in congenital cataract. In summary, this
study identified variations in 28 of 30 congenital cataract
patients in north Indian population. Crystallin family (α- and
γ-crystallin)  accounts  for  66%  of  the  variations  whereas
connexins accounts for 44% of the total variations. It is notable
that  only  two  variations  (CRYGC:p.R48H  and
GJA8:p.L281C) in CRYGC and GJA8 detected in this study
were predicted to be pathogenic which may cause congenital
cataract. This study further confirms that CRYGC and GJA8
play a major role in the maintenance of lens transparency and
expands the mutation spectrum of both the genes in congenital
cataract.
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